Followers | 3181 |
Posts | 208744 |
Boards Moderated | 2 |
Alias Born | 02/04/2004 |
Friday, June 21, 2019 8:42:12 AM
And then we're finally going to see the importance and significance of exactly why VYST needed this final key leverageable Rotmans building block inserted into the foundation as they prepare to unleash a commercialization era for the OTC ages!
We know with total and complete certainty that VYST's been through 1 of the most extensive R&D era's imaginable with a multitude of relevant big names too...so all the pending growth potential over the very near term horizon is definitely no joke, as I definitely feel that VYST has major commercialization launch endeavors en route that consist of an absolute multitude of fresh and extremely relevant valuation driving goodies!
We should be talking about big name contracts, joint ventures, major manufacturer partners, national and international product rollouts, accompanying mainstream branding campaigns, additional asset purchases, additional accretive company acquisitions, major investment banking friendly financing partners, their long awaited up listing journey finally initiating etc etc etc...as VYST finally hits the ground running with an entire stable of proprietary competitive advantage products from FEC and Vytex alone that deliver 1 of this summers most dramatic, explosive and impactful rapid growth curves unleashed on the entire OTC!
And when they do finally start unleashing all of it while simultaneously embarking on their up listing journey...much higher breeds of investors and firms will begin arriving in multiple waves of position building fun while simultaneously having to constantly apply ever increasing valuation metrics onto VYST's rapidly unfolding growth equation all summer long, as CEO Rotman begins immediately unleashing this growth driving BEAST in the soon to be post Rotmans leverage era upon us!
They're definitely building it, and much bigger boys are definitely coming:)
Recent VYST News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 05:32:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 08:06:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 11:01:23 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 10:21:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 07:36:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/26/2023 06:46:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/26/2023 06:41:50 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/10/2023 09:14:55 PM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM